ArcScan
PrivateLast Round
Series B
Jul 21, 2021
Total Funding Raised
$16.05M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ArcScan operates in Healthcare & Life Sciences and is based in Golden, Colorado. Its latest recorded funding round was a Series B round in July 2021.
ArcScan is a medical technology company that develops and manufactures an intelligent anterior segment imaging system using very high-frequency ultrasound for ophthalmic procedures.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ArcScan Comparables
Compare ArcScan with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DGH Technology | 76% | |
| Sonomed Escalon | 76% | |
| Carl Zeiss Meditec AG | 75% |
For institutional investors. Book with your work email.
ArcScan Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 21, 2021 | ||||
| Series A | Feb 1, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ArcScan Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cornell University Office of University Investments | Series A |
| Kevin M. McGovern Family Center for Venture Development in the Life Sciences | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 106% MoM.
- May 3, 2025
Monthly visitors increased 145% MoM.
For institutional investors. Book with your work email.
ArcScan Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ArcScan's valuation, stock price, and market status.
Is ArcScan a public or private company?
ArcScan is a private company.
What is the current stock price of ArcScan?
ArcScan is a private company, so its shares have no public market price. Caplight tracks ArcScan's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ArcScan worth (valuation)?
Valuation information for ArcScan is not publicly available.
Can I buy ArcScan stock?
ArcScan shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ArcScan's last funding round?
ArcScan's most recent funding round was Series B on July 21, 2021.
Who are the main investors in ArcScan?
Key investors in ArcScan include Cornell University Office of University Investments, Kevin M. McGovern Family Center for Venture Development in the Life Sciences.
Will ArcScan IPO soon?
No public IPO plans have been announced for ArcScan.
How can I track ArcScan secondary market activity?
Caplight tracks bids, offers, and trades in ArcScan's shares on secondary markets.